|
Q4 FY2025
As of Dec 31, 2025
|
Q2 FY2026
As of Jul 12, 2026
|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|---|---|
| Current assets: | |||
| Cash and cash equivalents | |||
| Trade receivables | |||
| Inventories | |||
| Prepayments and other current assets | |||
| Total current assets | |||
| Property, plant and equipment, net | |||
| Deposits paid for non-current assets | |||
| Right-of-use assets | |||
| Deferred tax assets | |||
| Total non-current assets | |||
| Total assets | |||
| Current liabilities: | |||
| Bank overdraft | |||
| Short-term bank borrowings | |||
| Trade payables | |||
| Accruals and other payables | |||
| Amounts due to related parties | |||
| Related Party | |||
| Total amounts due to related parties | |||
| Lease liabilities, current portion | |||
| Income tax payable | |||
| Total current liabilities | |||
| Lease liabilities, non-current portion | |||
| Total non-current liabilities | |||
| Total liabilities | |||
| Shareholders’ equity | |||
| Ordinary shares (US$0.016** par value, 6,250,000** shares authorized, 1,100,625** shares issued and outstanding as of December 31, 2024 and US$0.016 par value, 6,125,000 shares authorized, 4,206,788 shares issued and outstanding as of December 31, 2025) | |||
| Founders Preferred Shares (US$0.016** par value, 125,000** shares authorized, 125,000** shares issued and outstanding as of December 31, 2025) | |||
| Receivables from shareholders | |||
| Share premium | |||
| Retained profits | |||
| Accumulated other comprehensive loss | |||
| Other reserves | |||
| Total shareholders’ equity | |||
| Total liabilities and shareholders’ equity |
Loading...
